ATE305452T1 - Faktor xa inhibitor - Google Patents

Faktor xa inhibitor

Info

Publication number
ATE305452T1
ATE305452T1 AT02778933T AT02778933T ATE305452T1 AT E305452 T1 ATE305452 T1 AT E305452T1 AT 02778933 T AT02778933 T AT 02778933T AT 02778933 T AT02778933 T AT 02778933T AT E305452 T1 ATE305452 T1 AT E305452T1
Authority
AT
Austria
Prior art keywords
inhibitor
factor
Prior art date
Application number
AT02778933T
Other languages
German (de)
English (en)
Inventor
Gary Lowell Engel
Benjamin Alan Diseroad
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2001/002553 external-priority patent/WO2001096323A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE305452T1 publication Critical patent/ATE305452T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02778933T 2001-06-12 2002-06-06 Faktor xa inhibitor ATE305452T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2001/002553 WO2001096323A1 (en) 2000-06-13 2001-06-12 Serine protease inhibitors
US33929501P 2001-12-12 2001-12-12
PCT/US2002/016569 WO2002100847A2 (en) 2001-06-12 2002-06-06 Factor xa inhibitor

Publications (1)

Publication Number Publication Date
ATE305452T1 true ATE305452T1 (de) 2005-10-15

Family

ID=41210812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02778933T ATE305452T1 (de) 2001-06-12 2002-06-06 Faktor xa inhibitor

Country Status (13)

Country Link
US (1) US20040162295A1 (enExample)
EP (1) EP1397348B1 (enExample)
JP (1) JP2004534062A (enExample)
AR (1) AR036048A1 (enExample)
AT (1) ATE305452T1 (enExample)
AU (1) AU2002348501A1 (enExample)
DE (1) DE60206376T2 (enExample)
ES (1) ES2248618T3 (enExample)
MY (1) MY137876A (enExample)
PE (1) PE20030198A1 (enExample)
SV (1) SV2003001085A (enExample)
TW (1) TWI257389B (enExample)
WO (1) WO2002100847A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010160A2 (en) * 2001-07-26 2003-02-06 Eli Lilly And Company 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
HRP20040900B1 (en) 2002-04-01 2006-02-28 Eli Lilly And Company Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>
CA2570634A1 (en) * 2004-06-30 2006-02-02 Eli Lilly And Company 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate
KR100849242B1 (ko) * 2004-06-30 2008-07-29 일라이 릴리 앤드 캄파니 1(인돌-6-카르보닐-ｄ-페닐글리시닐)-4-(1-메틸피페리딘-4-일) 피페라진 ｄ-타르트레이트
DE102007028406A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028319A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028407A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2014012859A1 (en) * 2012-07-19 2014-01-23 Boehringer Ingelheim International Gmbh Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as medicament and the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375920A1 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds

Also Published As

Publication number Publication date
MY137876A (en) 2009-03-31
EP1397348B1 (en) 2005-09-28
US20040162295A1 (en) 2004-08-19
WO2002100847A3 (en) 2003-08-21
PE20030198A1 (es) 2003-03-12
ES2248618T3 (es) 2006-03-16
TWI257389B (en) 2006-07-01
DE60206376D1 (de) 2006-02-09
DE60206376T2 (de) 2006-06-22
AU2002348501A1 (en) 2002-12-23
AR036048A1 (es) 2004-08-04
WO2002100847A2 (en) 2002-12-19
SV2003001085A (es) 2003-03-18
JP2004534062A (ja) 2004-11-11
EP1397348A2 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
NO20021230L (no) Faktor Xa inhibitorer
AU2002350217A8 (en) Glycinamides as factor xa inhibitors
NO20041163L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
FI20011999L (fi) Biohajoava pinnoite
CY2015028I2 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
DE60234125D1 (de) E inhibitoren
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
AU2002365896A8 (en) Substituted amino methyl factor xa inhibitors
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DE60217588D1 (de) Verdichterbeschichtung
DK1395553T3 (da) Pyrrolidinderivater som faktor Xa-inhibitorer
DK1189929T3 (da) Faktor VIIa-inhibitorer
ATA8182001A (de) Fluorometer
DE60206376D1 (de) Faktor xa inhibitor
NO20013535L (no) Nöytrofil-funksjons-inhibitorer
NO20015983D0 (no) Sangmikrofon
DK1456482T3 (da) Gipsplade
DE60203837D1 (de) Verdichterbeschichtung
DE60206558D1 (de) Beschichtung
NO20015984D0 (no) Sangmikrofon
DE50214718D1 (de) Montagewinkel
SE0102987D0 (sv) Länsa
DK1357966T3 (da) Dispenser
FI20010844L (fi) Uusi äidinmaidonkorvikekoostumus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties